Hypertension: Cordis lands Euro approval for Renlane renal denervation

Johnson & Johnson subsidiary Cordis Corp. wins European CE Mark approval for its Renlane renal denervation system for treating patients with resistant hypertension.

Cordis Corp., Johnson & Johnson

News Well, Ablation, Hypertension, Regulatory/Clearance, CE Mark, Renal

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/OjPlPy